# Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

> **NCT00608517** · NA · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide
- **DRUG:** fludarabine phosphate
- **DRUG:** methylprednisolone
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00608517
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2008-03
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608517, "Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00608517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*